Financing co-led by new investor BRM Group and existing investor Pontifax. Lead program KM023 is a first-in-class oral TRPV3 inhibitor entering clinical development for the treatm ...

Palmoplantar Keratoderma and Severe Atopic DermatitisThird Quoin Patent Application for Netherton Syndrome If Granted Company Would have Patent Protection for QRX003 for Netherton Syndrome Until ...

A 24-year-old white male presented with a 2-year history of changes to his nails. He stated that the white discoloration had never completely resolved but improved from time to time with the nails ...

A focused evaluation of scalp hair should be part of every newborn physical assessment. Although typically completed in the delivery room, it may be useful to re-evaluate the infant after the ...